Axel Pähler

1.2k total citations
34 papers, 892 citations indexed

About

Axel Pähler is a scholar working on Molecular Biology, Pharmacology and Biochemistry. According to data from OpenAlex, Axel Pähler has authored 34 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Pharmacology and 9 papers in Biochemistry. Recurrent topics in Axel Pähler's work include Pharmacogenetics and Drug Metabolism (11 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Carcinogens and Genotoxicity Assessment (6 papers). Axel Pähler is often cited by papers focused on Pharmacogenetics and Drug Metabolism (11 papers), Metabolomics and Mass Spectrometry Studies (8 papers) and Carcinogens and Genotoxicity Assessment (6 papers). Axel Pähler collaborates with scholars based in Switzerland, Germany and United States. Axel Pähler's co-authors include Wolfgang Völkel, W. Dekant, Rubén Alvarez‐Sánchez, Holger Fischer, Wolfgang Muster, Lutz Müller, Alexander Breidenbach, Stephan Kirchner, Andreas Brink and Jean Parker and has published in prestigious journals such as Neuron, Analytical Chemistry and Analytical Biochemistry.

In The Last Decade

Axel Pähler

32 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Pähler Switzerland 16 414 193 173 117 116 34 892
John R. Soglia United States 16 386 0.9× 461 2.4× 161 0.9× 88 0.8× 191 1.6× 20 956
Fumiaki Shono Japan 15 226 0.5× 118 0.6× 93 0.5× 86 0.7× 94 0.8× 54 657
Timothy J. Carlson United States 19 215 0.5× 201 1.0× 209 1.2× 36 0.3× 73 0.6× 49 1.1k
Toshimasa Itoh Japan 22 791 1.9× 177 0.9× 99 0.6× 126 1.1× 47 0.4× 68 1.5k
Robert A. Jolly United States 22 728 1.8× 167 0.9× 316 1.8× 213 1.8× 78 0.7× 44 1.4k
John C. L. Erve United States 17 371 0.9× 367 1.9× 116 0.7× 29 0.2× 226 1.9× 26 1.0k
Anders Tunek Sweden 23 465 1.1× 226 1.2× 112 0.6× 333 2.8× 114 1.0× 42 1.7k
Zuyu Guo United States 18 635 1.5× 507 2.6× 72 0.4× 191 1.6× 65 0.6× 24 1.2k
Dieter Schwarz Germany 18 539 1.3× 461 2.4× 81 0.5× 98 0.8× 63 0.5× 51 1.0k
Hsia-lien Lin United States 17 249 0.6× 467 2.4× 107 0.6× 40 0.3× 61 0.5× 26 799

Countries citing papers authored by Axel Pähler

Since Specialization
Citations

This map shows the geographic impact of Axel Pähler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Pähler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Pähler more than expected).

Fields of papers citing papers by Axel Pähler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Pähler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Pähler. The network helps show where Axel Pähler may publish in the future.

Co-authorship network of co-authors of Axel Pähler

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Pähler. A scholar is included among the top collaborators of Axel Pähler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Pähler. Axel Pähler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walles, Markus, et al.. (2023). Meeting report of the 3rd European Biotransformation Workshop. Xenobiotica. 53(2). 123–127.
2.
Honer, Michael, Alessandra Polara, Hiroto Kuwabara, et al.. (2023). RO6807936 as a novel positron emission tomography (PET) radiotracer for in vitro and in vivo visualization and quantification of beta‐site amyloid precursor protein cleaving enzyme (BACE1) in the rodent and baboon brain. Journal of Labelled Compounds and Radiopharmaceuticals. 66(9). 222–236. 1 indexed citations
3.
Walles, Markus, Axel Pähler, Emre M. Isin, & Lars Weidolf. (2022). Meeting report of the second European biotransformation workshop. Xenobiotica. 52(4). 426–431. 2 indexed citations
4.
Walles, Markus, Axel Pähler, Lars Weidolf, & Emre M. Isin. (2021). Meeting report of the first European biotransformation workshop. Xenobiotica. 51(9). 1081–1086. 1 indexed citations
5.
Borroni, Edilio, Bernd Bohrmann, Fiona Grueninger, et al.. (2017). Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease. Journal of Pharmacology and Experimental Therapeutics. 362(3). 413–423. 75 indexed citations
7.
Brink, Andreas, Axel Pähler, Christoph Funk, Franz Schuler, & Simone Schadt. (2016). Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design. Drug Discovery Today. 22(5). 751–756. 30 indexed citations
8.
Zell, M., Christophe Husser, Roland F. Staack, et al.. (2016). In Vivo Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 Analyzed by Ligand-Binding Mass Spectrometry Combined with Quantitation by ELISA. Analytical Chemistry. 88(23). 11670–11677. 15 indexed citations
9.
Fontaine, Fabien, et al.. (2015). Software‐aided cytochrome P450 reaction phenotyping and kinetic analysis in early drug discovery. Rapid Communications in Mass Spectrometry. 30(2). 301–310. 10 indexed citations
11.
Heinig, Katja, Franz Bucheli, Olaf Kuhlmann, et al.. (2012). Determination of dalcetrapib by liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 66. 314–324. 12 indexed citations
12.
Lavé, Thierry, et al.. (2009). In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human. Toxicology Letters. 190(3). 303–309. 14 indexed citations
13.
Tzouros, Manuel & Axel Pähler. (2009). A Targeted Proteomics Approach to the Identification of Peptides Modified by Reactive Metabolites. Chemical Research in Toxicology. 22(5). 853–862. 20 indexed citations
14.
15.
Pähler, Axel, Jean Parker, & Wolfgang Dekant. (1999). Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation. Toxicological Sciences. 48(1). 5–13. 20 indexed citations
17.
Pähler, Axel, et al.. (1999). Quantitation of α2u-Globulin in Rat Kidney Cytosol by Capillary Electrophoresis. Analytical Biochemistry. 267(1). 203–211. 6 indexed citations
20.
Pähler, Axel, Gerhard Birner, Mary Jane Ott, & W. Dekant. (1997). Binding of Hexachlorobutadiene to α-Globulin and Its Role in Nephrotoxicity in Rats. Toxicology and Applied Pharmacology. 147(2). 372–380. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026